Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#50 of 1,184)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 2 news outlets

twitter: 42 X users

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 203 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 2 outlets.

What is Severe Insulin-Deficient Diabetes (SIDD)?

Verywell Health, 03 Feb 2023

Severe insulin-deficient diabetes (SIDD) is a subtype of type 2 diabetes. Healthcare providers use subcategories to classify…

What Is Severe Insulin-Resistant Diabetes (SIRD)

Verywell Health, 23 Dec 2022

Severe insulin-resistant diabetes (SIRD) is a subgroup of type 2 diabetes. While symptoms of SIRD are the same as other forms…

Cardiologists Should Be More Involved in Treating NAFLD/NASH

Medscape, 24 May 2021

This transcript has been edited for clarity. Seth J. Baum, MD, FACC, FAHA, FNLA, FASPC: Hi.